Metraipolis › archive › dc_f832017ca03f

Efficacy and safety of intralymphatic immunotherapy for allergic rhinitis: an overview of systematic reviews and meta analyses — Europe PMC PMID:41426588

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41426588
DOI: 10.3389/fmed.2025.1709531
License (as archived): solo-consultazione
Archived: 2026-11-07T21:48:08.806Z
SHA-256 of the archived text: e07f30b208c6a12f7d9be6efe798d23b343037f45efdf508e159c5ef1885c12a
Stable URL of this page: https://metraipolis.com/documento/dc_f832017ca03f

How to cite

Efficacy and safety of intralymphatic immunotherapy for allergic rhinitis: an overview of systematic reviews and meta analyses — Europe PMC PMID:41426588 — Europe PMC (en), https://europepmc.org/article/MED/41426588 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f832017ca03f (Metraipolis archive dc_f832017ca03f, sha256 e07f30b208c6a12f7d9be6efe798d23b343037f45efdf508e159c5ef1885c12a)

BibTeX

@misc{dcf832017ca03f,
  title = {Efficacy and safety of intralymphatic immunotherapy for allergic rhinitis: an overview of systematic reviews and meta analyses — Europe PMC PMID:41426588},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41426588},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f832017ca03f; sha256 e07f30b208c6a12f7d9be6efe798d23b343037f45efdf508e159c5ef1885c12a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41426588. Agents can read the archived copy with the MCP tool read_document.